1. Home
  2. TITN vs RLMD Comparison

TITN vs RLMD Comparison

Compare TITN & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Titan Machinery Inc.

TITN

Titan Machinery Inc.

HOLD

Current Price

$23.37

Market Cap

479.3M

ML Signal

HOLD

Logo Relmada Therapeutics Inc.

RLMD

Relmada Therapeutics Inc.

HOLD

Current Price

$4.55

Market Cap

461.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TITN
RLMD
Founded
1980
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
479.3M
461.9M
IPO Year
2007
2012

Fundamental Metrics

Financial Performance
Metric
TITN
RLMD
Price
$23.37
$4.55
Analyst Decision
Hold
Strong Buy
Analyst Count
3
5
Target Price
$19.00
$12.40
AVG Volume (30 Days)
302.0K
936.8K
Earning Date
05-21-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
45.28
EPS
N/A
N/A
Revenue
$2,427,107,000.00
$13,070.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.75
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
154.83
52 Week Low
$13.21
$1.45
52 Week High
$26.90
$8.00

Technical Indicators

Market Signals
Indicator
TITN
RLMD
Relative Strength Index (RSI) 61.10 28.25
Support Level $15.86 $3.98
Resistance Level $25.00 $4.44
Average True Range (ATR) 1.70 0.19
MACD 0.57 -0.00
Stochastic Oscillator 68.44 9.21

Price Performance

Historical Comparison
TITN
RLMD

About TITN Titan Machinery Inc.

Titan Machinery Inc owns and operates a network of full-service agricultural and construction equipment stores. The company sells and repairs agricultural equipment, including machinery and attachments for large-scale farming and home and gardening purposes, as well as construction equipment. It operates through following segments: The Agriculture segment sells, services, and rents machinery and related parts and attachments, for uses ranging from large-scale farming to home and garden use, The construction segment sells, services, and rents machinery, and related parts and attachments, for uses ranging from heavy construction to light industrial machinery use, and the Europe and Australia segments.

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.

Share on Social Networks: